Targeting anti-tumor CP protein CRB3 can inhibit tumor growth and lung metastasis [43], and LKB1 overexpression suppresses growth, microvascular density, and lung metastasis in LKB1-deficient MDA-MB-435 cells [145]. Here, CRB3 is linked to neoplasm.